Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJNYSE:JPM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$153.88-0.2%$157.67$140.68▼$169.99$370.24B0.427.87 million shs9.02 million shsJPMJPMorgan Chase & Co.$259.67+2.6%$238.44$190.88▼$280.25$721.66B1.079.60 million shs9.59 million shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson-0.07%-0.73%+1.49%-1.47%+2.65%JPMJPMorgan Chase & Co.+2.56%+2.87%+9.91%-5.62%+30.64%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJNJJohnson & Johnson4.8529 of 5 stars3.33.04.23.93.42.51.3JPMJPMorgan Chase & Co.4.5995 of 5 stars2.33.04.22.02.13.32.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.63Moderate Buy$171.8211.66% UpsideJPMJPMorgan Chase & Co. 2.50Moderate Buy$255.67-1.54% DownsideCurrent Analyst Ratings BreakdownLatest JNJ and JPM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/24/2025JNJJohnson & JohnsonBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/17/2025JNJJohnson & JohnsonBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$166.00 ➝ $165.004/17/2025JPMJPMorgan Chase & Co.UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$277.00 ➝ $305.004/16/2025JNJJohnson & JohnsonSanford C. BernsteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/16/2025JNJJohnson & JohnsonRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.004/16/2025JNJJohnson & JohnsonMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$164.00 ➝ $169.004/14/2025JPMJPMorgan Chase & Co.Truist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$261.004/14/2025JNJJohnson & JohnsonRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$165.00 ➝ $162.004/14/2025JPMJPMorgan Chase & Co.Truist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$264.00 ➝ $251.004/13/2025JPMJPMorgan Chase & Co.KGI SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold4/10/2025JNJJohnson & JohnsonBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$171.00 ➝ $159.00(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$89.33B4.14$12.64 per share12.17$29.69 per share5.18JPMJPMorgan Chase & Co.$172.86B4.17$21.43 per share12.12$116.13 per share2.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$8.9923.1413.902.5618.20%34.24%13.63%7/16/2025 (Estimated)JPMJPMorgan Chase & Co.$58.47B$20.3713.1513.372.8320.96%16.99%1.31%7/11/2025 (Estimated)Latest JNJ and JPM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/15/2025Q1 2025JNJJohnson & Johnson$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion4/11/2025Q1 2025JPMJPMorgan Chase & Co.$4.63$5.07+$0.44$5.07$43.62 billion$45.30 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.203.38%+5.43%57.84%64 YearsJPMJPMorgan Chase & Co.$5.602.16%+8.10%27.49%15 YearsLatest JNJ and JPM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/15/2025JNJJohnson & Johnsonquarterly$1.303.37%5/27/20255/27/20256/10/20253/18/2025JPMJPMorgan Chase & Co.quarterly$1.402.38%4/4/20254/4/20254/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.431.110.86JPMJPMorgan Chase & Co.1.240.880.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%JPMJPMorgan Chase & Co.71.55%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%JPMJPMorgan Chase & Co.0.47%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson152,7002.41 billion2.40 billionOptionableJPMJPMorgan Chase & Co.293,7002.78 billion2.77 billionOptionableJNJ and JPM HeadlinesRecent News About These CompaniesOne Year On, JPMorganChase Shares Progress on £40M Investment in the U.K. and Deploys £3.3M to Boost Career Opportunities Across the CountryMay 13 at 3:30 AM | businesswire.comSean Combs' jury has been selected. The trial is officially underway. - NPRMay 12 at 6:35 PM | news.google.comODD: JPMorgan Leads as Sole Bookrunner in Latest Offering | ODD Stock NewsMay 12 at 6:10 PM | gurufocus.comJPMorganChase to Present at the Morgan Stanley U.S. Financials ConferenceMay 12 at 6:10 PM | gurufocus.comJPMorganChase to Present at the Morgan Stanley U.S. Financials ConferenceMay 12 at 5:06 PM | businesswire.comJP Morgan CEO Jamie Dimon slams Democrats for LA wildfire reconstruction delays, ‘more regulations’May 12 at 4:47 PM | msn.comCampbell Global Announces Leadership Transition: Angie Davis to Succeed John Gilleland as CEOMay 12 at 4:29 PM | gurufocus.comJPMorgan Adjusts Price Target for ARZGY to EUR 32, Maintains Neutral Rating | ARZGY Stock NewsMay 12 at 4:29 PM | gurufocus.comJPMorgan Increases Price Target for Vivendi (VIVHY) Shares | VIVHY Stock NewsMay 12 at 4:29 PM | gurufocus.comJPMorgan Adjusts Price Target for Knorr-Bremse (KNRRY) | KNRRY Stock NewsMay 12 at 4:29 PM | gurufocus.comUnder Armour Q4 Earnings Preview: Are Investors 'Better Off Hiding Out, Literally, Under Armor' Than Buying Stock?May 12 at 4:29 PM | benzinga.comBlade Air Mobility to Present at the 2025 J.P. ...May 12 at 3:02 PM | gurufocus.comMP Materials (MP) Price Target Lowered by JP Morgan | MP Stock NewsMay 12 at 3:02 PM | gurufocus.comJP Morgan Raises Price Target for Starwood Property Trust (STWD) | STWD Stock NewsMay 12 at 3:02 PM | gurufocus.comCellebrite DI (CLBT) Price Target Lowered by JP Morgan | CLBT Stock NewsMay 12 at 3:02 PM | gurufocus.comJP Morgan Adjusts Price Target for Rapid7 (RPD) | RPD Stock NewsMay 12 at 3:02 PM | gurufocus.comBCE Target Price Raised to CAD 29.00 by JP Morgan | BCE Stock NewsMay 12 at 3:02 PM | gurufocus.comJP Morgan Updates Sweetgreen (SG) Price Target and Maintains Neutral Rating | SG Stock NewsMay 12 at 3:02 PM | gurufocus.comSKM Downgraded by JP Morgan from Overweight to Neutral | SKM Stock NewsMay 12 at 3:02 PM | gurufocus.comCampbell Global Announces Leadership Transition: Angie Davis to Succeed John Gilleland as CEOMay 12 at 3:00 PM | prnewswire.comInvestment Management Corp of Ontario Decreases Stake in JPMorgan Chase & Co. (NYSE:JPM)May 12 at 8:31 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum3 High-Yield Dividend Stocks That Could Rally Near 52-Week LowsBy Chris Markoch | May 1, 2025View 3 High-Yield Dividend Stocks That Could Rally Near 52-Week Lows3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.By Leo Miller | April 28, 2025View 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy? By Chris Markoch | April 16, 2025View Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy? JNJ and JPM Company DescriptionsJohnson & Johnson NYSE:JNJ$153.88 -0.34 (-0.22%) Closing price 05/12/2025 03:59 PM EasternExtended Trading$154.24 +0.36 (+0.23%) As of 04:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.JPMorgan Chase & Co. NYSE:JPM$259.67 +6.59 (+2.61%) Closing price 05/12/2025 03:59 PM EasternExtended Trading$259.50 -0.17 (-0.07%) As of 04:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
